Henry Schein, Inc.

Henry Schein, Inc., through its USDG Federal Division, is a Fortune 500 medical and dental supply distributor that operates as a prime contractor across 232 federal customer agencies, delivering medical consumables, surgical equipment, dental supplies, diagnostic materials, and laboratory equipment to federal healthcare facilities, military medical operations, and civilian agencies. The company competes exclusively in full-and-open procurement — no set-aside designations mark any of its awards — and holds a dominant position on the Defense Logistics Agency's Electronic Catalog (ECAT) program, where it maintains a $30 million single-award Indefinite Delivery Contract (IDC #4610117412) running through April 22, 2030.

Henry Schein's customer concentration is extreme and structural. The Defense Logistics Agency Troop Support Medical accounts for 477,197 awards valued at $2.47 billion combined potential value — representing 94% of recent awards by count and 48% by dollars. This is not a competitive posture but a de facto monopoly vehicle: the single IDC serves as the foundational platform for hundreds of thousands of micro-transactions (delivery orders ranging from $4 to tens of thousands of dollars) flowing to federal medical supply end-users. The next four customers by award count — the Indian Health Service (1,235 awards, $45.3 million), the Navy Bureau of Medicine and Surgery (191 awards, $7.6 million), the Army Medical Command (152 awards, $5.2 million), and Veterans Integrated Service Network 8 (90 awards, $2.2 million) — account for less than 1 percent of Henry Schein's dollar volume and are chiefly BPA calls and purchase orders for specific equipment or consumables, not structural vehicles. The portfolio's top five parent IDCs are all Defense Logistics Agency SPE2DE-series contracts: SPM2DE14D7469 (189,012 task orders, $134.5 million), SPE2DE19D0010 (143,845 task orders, $70.9 million), SPE2DE15D0007 (41,496 task orders, $11 million), SPE2DE24D0026 (40,984 task orders, $23 million), and SPE2DE20D0012 (22,779 task orders, $7.4 million). Together these five vehicles account for the vast majority of Henry Schein's federal services revenue, all flowing through the DLA's electronic catalog procurement system.

Activity has declined year over year: 34,403 awards in 2022 to 9,819 in 2026 (through June). This decline reflects the maturation of the DLA ECAT program toward consolidation and potentially reflects competitive or administrative pressures on delivery order volume. Henry Schein faces minimal near-term recompete exposure: only 11 awards (combined potential value $3.6 million) complete in the next twenty-four months. The extended recompete window — most underlying IDCs run through 2029 and 2030 — provides substantial protection from near-term displacement, but the sheer concentration of revenue on a handful of DLA vehicles creates strategic vulnerability if DLA were to add additional awardees or restructure the ECAT program.

Capability profile centers on medical and dental supply wholesale distribution. The source lists 466,919 awards under NAICS 424210 (Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers), with secondary awards in dental equipment manufacturing (16,823), surgical and medical instrument manufacturing (3,708), medicinal and botanical manufacturing (3,269), and photographic materials manufacturing (1,085). By PSC, Laboratory Equipment and Supplies (425,344 awards) dominates, followed by Medical and Surgical Instruments, Equipment, and Supplies (35,609), Dental Instruments, Equipment, and Supplies (22,755), Ophthalmic Instruments, Equipment, and Supplies (10,415), and Drugs and Biologicals (7,192). Representative delivery orders issued in April and June 2026 under the $30 million DLA IDC include dental composites (Filtek Supreme Ultra capsules), anesthetics (Marcaine, Septocaine, Lidocaine cartridges), surgical supplies (carbide burs, gauze, surgical tape), diagnostic test strips (CoaguCheck XS, Clinitek), laboratory consumables (specimen cups, pipets, suction tubing), and hygiene supplies (Kleenex towels, alcohol prep pads, Castile soap wipes). Henry Schein also holds a $150,000 BPA call with the Indian Health Service's Albuquerque facility (June 1, 2026, exercised option 2, completion May 31, 2027) and purchase orders from Federal Correctional Institution Edgefield ($5,000, June 4, 2026), Federal Correctional Institution Memphis ($18,161, May 18, 2026), and Veterans Integrated Service Network 9 ($37,361 for dental vacuum equipment, May 14, 2026), and Indian Health Service ($97,412 for dental equipment at Charles City, Virginia, May 8, 2026).

The corporate structure includes 16 named subsidiaries, several of which carry manufacturing and specialty-supply brands: ACE Surgical Supply Co., Inc. (surgical supply manufacturer), Ortho Technology, Inc., Biohorizons Implant Systems Inc. (implant systems manufacturer), and Handpiece Parts & Repairs, Inc. (dental equipment service). Henry Schein operates as a 100-percent prime contractor across its federal footprint — the award portfolio lists no material subcontractor role, and Service Contract Inventory data show only 4.1 FTEs in FY2024 (all as a named subcontractor, likely a small medical supplies support sub for KBR on an Iraq-based medical services contract, valued at an immaterial amount). The vendor's federal profile is therefore a pure-play distributor prime, with no strategic teaming or sub-heavy delivery model. Combined potential value across all 508,469 awards stands at $5.3 billion, with $580.2 million obligated to date (11% of potential value), reflecting Henry Schein's dominance in federal medical supply fulfillment but also the long-tail nature of delivery-order based procurement: thousands of small orders aggregate into massive volumes over multi-year IDCs with extended completion dates.